Research programme: nitric oxide synthase modulators - Apex Bioscience

Drug Profile

Research programme: nitric oxide synthase modulators - Apex Bioscience

Alternative Names: Nitric oxide synthase modulators research programme - Apex Bioscience

Latest Information Update: 22 Dec 2000

Price : $50

At a glance

  • Originator Curacyte Inc
  • Class Small molecules
  • Mechanism of Action Nitric oxide synthase inhibitors; Nitric oxide synthase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Autoimmune disorders; Cardiovascular disorders; CNS disorders

Most Recent Events

  • 22 Dec 2000 Discontinued-Preclinical for Autoimmune disorders in USA (Unknown route)
  • 22 Dec 2000 Discontinued-Preclinical for Cardiovascular disorders in USA (Unknown route)
  • 22 Dec 2000 Discontinued-Preclinical for CNS disorders in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top